why choose us

First received: October 02, 2023

Clinical Trial: A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Prostatic Neoplasms

Study Type: OBSERVATIONAL


Official Title: Novel Hormonal Therapies (NHTs) for the Treatment of Metastatic Castration-sensitive Prostate Cancer (mCSPC) in the Medicare Population

Brief Summary: The purpose of this study is to learn about how long novel hormonal therapies are taken by men to treat mCSPC.Novel hormonal therapies in this study include study medicines abiraterone, apalutamide, and enzalutamide.Prostate cancer is one of the most common cancers in men.The prostate is a gland in the male body that helps make semen.Metastatic cancer is a cancer that has spread to other parts of the body.Castration-sensitive prostate cancer means the cancer is being controlled by keeping the testosterone levels…

Read more